Amit Hazan
Stock Analyst at Goldman Sachs
(2.11)
# 2,969
Out of 5,076 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $126.34 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $7.61 | -67.15% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.49 | +1,175.17% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $17.35 | -53.89% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $63.11 | -0.17% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $191.82 | +41.80% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $16.56 | +2.66% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $4.22 | +10,208.06% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $30.41 | +44.69% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $85.27 | -14.39% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $19.08 | +177.78% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $29.36 | +94.14% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $21.96 | -56.74% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $128.01 | -18.76% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $18.08 | +231.86% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $103.34 | +11.28% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $372.32 | -59.71% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $101.01 | -54.46% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $567.37 | -57.41% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $94.76 | +86.79% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $205.34 | -28.41% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.02 | +282.35% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $126.34
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $7.61
Upside: -67.15%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.49
Upside: +1,175.17%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $17.35
Upside: -53.89%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $63.11
Upside: -0.17%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $191.82
Upside: +41.80%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $16.56
Upside: +2.66%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $4.22
Upside: +10,208.06%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $30.41
Upside: +44.69%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $85.27
Upside: -14.39%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $19.08
Upside: +177.78%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $29.36
Upside: +94.14%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $21.96
Upside: -56.74%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $128.01
Upside: -18.76%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $18.08
Upside: +231.86%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $103.34
Upside: +11.28%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $372.32
Upside: -59.71%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $101.01
Upside: -54.46%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $567.37
Upside: -57.41%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $94.76
Upside: +86.79%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $205.34
Upside: -28.41%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.02
Upside: +282.35%